Kingfa Science & Technology (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 24, 2025, 9:38 pm

Market Cap	3,752 Cr.
Current Price	3,095
High / Low	3,954/1,996
Stock P/E	24.5
Book Value	602
Dividend Yield	0.32 %
ROCE	30.6 %
ROE	23.2 %
Face Value	10.0
PEG Ratio	0.26

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Kingfa Science & Technology (India) Ltd

Competitors of Kingfa Science & Technology (India) Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Mitsu Chem Plast Ltd	155 Cr.	114	164/83.2	21.4	71.4	0.18 %	10.4 %	8.22 %	10.0
IIRM Holdings India Ltd	539 Cr.	79.2	172/30.7	24.1	19.4	0.00 %	23.5 %	18.6 %	5.00
Fiberweb (India) Ltd	148 Cr.	51.2	66.6/34.0	9.84	61.2	0.00 %	10.0 %	8.88 %	10.0
Deep Polymers Ltd	148 Cr.	61.2	93.1/35.7	28.6	36.2	0.00 %	8.22 %	6.08 %	10.0
DDev Plastiks Industries Ltd	2,825 Cr.	273	458/213	15.2	80.7	0.54 %	33.8 %	24.8 %	1.00
Industry Average	1,412.77 Cr	410.11		40.58	157.26	0.22%	16.41%	12.42%	8.25

All Competitor Stocks of Kingfa Science & Technology (India) Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	304	346	351	340	366	339	351	394	404	416	418	440	470
Expenses	287	338	317	310	311	289	306	356	354	359	362	389	409
Operating Profit	17	8	34	31	55	50	45	38	51	57	56	51	60
OPM %	6%	2%	10%	9%	15%	15%	13%	10%	13%	14%	13%	12%	13%
Other Income	-6	0	1	1	1	2	0	1	2	2	1	5	2
Interest	2	1	1	1	2	1	1	1	2	1	1	1	2
Depreciation	3	3	4	4	4	4	4	5	5	5	5	5	6
Profit before tax	5	3	30	27	49	47	40	32	45	52	50	49	54
Tax %	27%	27%	26%	25%	26%	25%	25%	25%	26%	25%	26%	30%	23%
Net Profit	4	2	22	20	37	35	30	24	34	39	37	35	42
EPS in Rs	3.30	2.04	18.24	16.70	30.24	28.93	24.44	20.09	27.70	32.26	30.77	28.60	34.60

Last Updated: May 31, 2025, 8:40 am

Below is a detailed analysis of the quarterly data for Kingfa Science & Technology (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 470.00 Cr.. The value appears strong and on an upward trend. It has increased from 440.00 Cr. (Dec 2024) to 470.00 Cr., marking an increase of 30.00 Cr..
For Expenses, as of Mar 2025, the value is 409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 389.00 Cr. (Dec 2024) to 409.00 Cr., marking an increase of 20.00 Cr..
For Operating Profit, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Dec 2024) to 60.00 Cr., marking an increase of 9.00 Cr..
For OPM %, as of Mar 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Dec 2024) to 13.00%, marking an increase of 1.00%.
For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to 2.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 5.00 Cr..
For Tax %, as of Mar 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Dec 2024) to 23.00%, marking a decrease of 7.00%.
For Net Profit, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Dec 2024) to 42.00 Cr., marking an increase of 7.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 34.60. The value appears strong and on an upward trend. It has increased from 28.60 (Dec 2024) to 34.60, marking an increase of 6.00.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:00 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	178	219	314	427	602	702	742	627	1,048	1,404	1,488	1,745
Expenses	181	212	288	408	560	666	698	607	966	1,276	1,303	1,520
Operating Profit	-3	6	27	19	41	35	43	20	82	128	185	225
OPM %	-2%	3%	8%	5%	7%	5%	6%	3%	8%	9%	12%	13%
Other Income	0	0	1	4	6	4	3	6	-22	2	3	9
Interest	7	8	7	2	2	2	4	3	5	7	6	7
Depreciation	3	3	3	3	6	8	9	11	13	14	18	22
Profit before tax	-12	-5	17	18	39	29	33	12	41	110	164	206
Tax %	-31%	-35%	38%	30%	36%	35%	26%	55%	26%	26%	25%	26%
Net Profit	-8	-3	11	12	25	19	25	5	31	81	123	153
EPS in Rs	-6.95	-2.49	8.93	10.24	20.35	15.74	20.33	4.39	25.29	67.22	101.17	126.22
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	10%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	62.50%	466.67%	9.09%	108.33%	-24.00%	31.58%	-80.00%	520.00%	161.29%	51.85%	24.39%
Change in YoY Net Profit Growth (%)	0.00%	404.17%	-457.58%	99.24%	-132.33%	55.58%	-111.58%	600.00%	-358.71%	-109.44%	-27.46%

Kingfa Science & Technology (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	23%
5 Years:	19%
3 Years:	19%
TTM:	17%

Compounded Profit Growth
10 Years:	48%
5 Years:	44%
3 Years:	48%
TTM:	25%

Stock Price CAGR
10 Years:	35%
5 Years:	53%
3 Years:	52%
1 Year:	56%

Return on Equity
10 Years:	14%
5 Years:	18%
3 Years:	22%
Last Year:	23%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:50 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6	6	10	10	12	12	12	12	12	12	12	12
Reserves	5	2	109	234	293	312	336	342	372	454	576	716
Borrowings	62	75	16	42	21	17	46	71	46	42	33	43
Other Liabilities	31	41	95	119	159	210	202	246	449	502	373	384
Total Liabilities	105	125	230	405	485	551	596	671	880	1,010	994	1,156
Fixed Assets	24	25	29	76	88	85	107	129	126	123	252	244
CWIP	0	1	41	10	2	79	115	123	127	131	2	41
Investments	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	81	99	160	319	395	388	375	419	627	756	740	871
Total Assets	105	125	230	405	485	551	596	671	880	1,010	994	1,156

Below is a detailed analysis of the balance sheet data for Kingfa Science & Technology (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
For Reserves, as of Mar 2025, the value is 716.00 Cr.. The value appears strong and on an upward trend. It has increased from 576.00 Cr. (Mar 2024) to 716.00 Cr., marking an increase of 140.00 Cr..
For Borrowings, as of Mar 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 33.00 Cr. (Mar 2024) to 43.00 Cr., marking an increase of 10.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 384.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 373.00 Cr. (Mar 2024) to 384.00 Cr., marking an increase of 11.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 1,156.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 994.00 Cr. (Mar 2024) to 1,156.00 Cr., marking an increase of 162.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 244.00 Cr.. The value appears to be declining and may need further review. It has decreased from 252.00 Cr. (Mar 2024) to 244.00 Cr., marking a decrease of 8.00 Cr..
For CWIP, as of Mar 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 41.00 Cr., marking an increase of 39.00 Cr..
For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Mar 2025, the value is 871.00 Cr.. The value appears strong and on an upward trend. It has increased from 740.00 Cr. (Mar 2024) to 871.00 Cr., marking an increase of 131.00 Cr..
For Total Assets, as of Mar 2025, the value is 1,156.00 Cr.. The value appears strong and on an upward trend. It has increased from 994.00 Cr. (Mar 2024) to 1,156.00 Cr., marking an increase of 162.00 Cr..

Notably, the Reserves (716.00 Cr.) exceed the Borrowings (43.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	-24	-1	19	-119	-116	96	30	-2	38	27	16	60
Cash from Investing Activity +	-1	-4	-47	-18	-6	-77	-63	-14	-19	-12	-5	-30
Cash from Financing Activity +	25	5	34	137	14	-7	22	17	-14	-21	-8	-7
Net Cash Flow	0	0	6	-1	-108	12	-11	1	5	-6	3	23

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-65.00	-69.00	11.00	-23.00	20.00	18.00	-3.00	-51.00	36.00	86.00	152.00	182.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	78	97	93	99	111	110	109	97	123	99	93	99
Inventory Days	52	54	64	85	69	85	63	67	100	110	94	76
Days Payable	68	66	72	127	108	108	119	115	152	181	155	110
Cash Conversion Cycle	62	85	85	57	72	86	53	49	71	28	32	66
Working Capital Days	57	90	87	66	82	99	59	69	82	48	56	86
ROCE %	-1%	-9%	4%	22%	9%	13%	9%	10%	4%	16%	25%	30%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
FIIs	6.33%	6.35%	6.34%	6.32%	6.32%	6.33%	6.34%	6.35%	6.36%	6.33%	6.34%	6.35%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%
Public	18.68%	18.66%	18.66%	18.69%	18.68%	18.67%	18.66%	18.66%	18.64%	18.67%	18.67%	18.61%
No. of Shareholders	8,178	8,682	9,022	8,794	8,205	7,975	8,490	9,419	9,266	9,452	9,414	10,566

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	101.17	67.22	25.29	4.39	20.33
Diluted EPS (Rs.)	101.17	67.22	25.29	4.39	20.33
Cash EPS (Rs.)	116.35	78.90	36.00	13.31	27.72
Book Value[Excl.RevalReserv]/Share (Rs.)	486.00	384.78	317.57	292.29	287.84
Book Value[Incl.RevalReserv]/Share (Rs.)	486.00	384.78	317.57	292.29	287.84
Dividend / Share (Rs.)	10.00	0.00	0.00	0.00	0.00
Revenue From Operations / Share (Rs.)	1228.45	1159.08	865.13	517.93	612.28
PBDIT / Share (Rs.)	155.39	107.56	68.41	21.43	37.86
PBIT / Share (Rs.)	140.21	95.89	57.70	12.52	30.46
PBT / Share (Rs.)	135.58	90.49	34.14	9.79	27.53
Net Profit / Share (Rs.)	101.17	67.22	25.29	4.39	20.33
PBDIT Margin (%)	12.64	9.27	7.90	4.13	6.18
PBIT Margin (%)	11.41	8.27	6.66	2.41	4.97
PBT Margin (%)	11.03	7.80	3.94	1.88	4.49
Net Profit Margin (%)	8.23	5.79	2.92	0.84	3.31
Return on Networth / Equity (%)	20.81	17.47	7.96	1.50	7.06
Return on Capital Employeed (%)	28.66	24.65	17.08	3.92	9.99
Return On Assets (%)	12.32	8.05	3.49	0.79	4.12
Long Term Debt / Equity (X)	0.00	0.00	0.04	0.06	0.05
Total Debt / Equity (X)	0.05	0.08	0.10	0.11	0.12
Asset Turnover Ratio (%)	1.48	1.49	1.35	0.98	1.29
Current Ratio (X)	1.80	1.37	1.30	1.45	1.59
Quick Ratio (X)	1.20	0.83	0.74	0.94	1.10
Inventory Turnover Ratio (X)	4.11	3.84	4.47	4.03	5.42
Interest Coverage Ratio (X)	33.55	19.95	15.67	7.84	12.92
Interest Coverage Ratio (Post Tax) (X)	22.84	13.47	11.19	2.61	7.94
Enterprise Value (Cr.)	2398.91	1621.01	1546.18	724.65	469.93
EV / Net Operating Revenue (X)	1.61	1.15	1.48	1.16	0.63
EV / EBITDA (X)	12.75	12.44	18.66	27.92	10.25
MarketCap / Net Operating Revenue (X)	1.60	1.14	1.46	1.13	0.60
Price / BV (X)	4.03	3.45	3.99	2.00	1.28
Price / Net Operating Revenue (X)	1.60	1.14	1.46	1.13	0.60
EarningsYield	0.05	0.05	0.01	0.01	0.05

After reviewing the key financial ratios for Kingfa Science & Technology (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 101.17. This value is within the healthy range. It has increased from 67.22 (Mar 23) to 101.17, marking an increase of 33.95.
For Diluted EPS (Rs.), as of Mar 24, the value is 101.17. This value is within the healthy range. It has increased from 67.22 (Mar 23) to 101.17, marking an increase of 33.95.
For Cash EPS (Rs.), as of Mar 24, the value is 116.35. This value is within the healthy range. It has increased from 78.90 (Mar 23) to 116.35, marking an increase of 37.45.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 486.00. It has increased from 384.78 (Mar 23) to 486.00, marking an increase of 101.22.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 486.00. It has increased from 384.78 (Mar 23) to 486.00, marking an increase of 101.22.
For Dividend / Share (Rs.), as of Mar 24, the value is 10.00. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 10.00, marking an increase of 10.00.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,228.45. It has increased from 1,159.08 (Mar 23) to 1,228.45, marking an increase of 69.37.
For PBDIT / Share (Rs.), as of Mar 24, the value is 155.39. This value is within the healthy range. It has increased from 107.56 (Mar 23) to 155.39, marking an increase of 47.83.
For PBIT / Share (Rs.), as of Mar 24, the value is 140.21. This value is within the healthy range. It has increased from 95.89 (Mar 23) to 140.21, marking an increase of 44.32.
For PBT / Share (Rs.), as of Mar 24, the value is 135.58. This value is within the healthy range. It has increased from 90.49 (Mar 23) to 135.58, marking an increase of 45.09.
For Net Profit / Share (Rs.), as of Mar 24, the value is 101.17. This value is within the healthy range. It has increased from 67.22 (Mar 23) to 101.17, marking an increase of 33.95.
For PBDIT Margin (%), as of Mar 24, the value is 12.64. This value is within the healthy range. It has increased from 9.27 (Mar 23) to 12.64, marking an increase of 3.37.
For PBIT Margin (%), as of Mar 24, the value is 11.41. This value is within the healthy range. It has increased from 8.27 (Mar 23) to 11.41, marking an increase of 3.14.
For PBT Margin (%), as of Mar 24, the value is 11.03. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 11.03, marking an increase of 3.23.
For Net Profit Margin (%), as of Mar 24, the value is 8.23. This value is within the healthy range. It has increased from 5.79 (Mar 23) to 8.23, marking an increase of 2.44.
For Return on Networth / Equity (%), as of Mar 24, the value is 20.81. This value is within the healthy range. It has increased from 17.47 (Mar 23) to 20.81, marking an increase of 3.34.
For Return on Capital Employeed (%), as of Mar 24, the value is 28.66. This value is within the healthy range. It has increased from 24.65 (Mar 23) to 28.66, marking an increase of 4.01.
For Return On Assets (%), as of Mar 24, the value is 12.32. This value is within the healthy range. It has increased from 8.05 (Mar 23) to 12.32, marking an increase of 4.27.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 24, the value is 0.05. This value is within the healthy range. It has decreased from 0.08 (Mar 23) to 0.05, marking a decrease of 0.03.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.48. It has decreased from 1.49 (Mar 23) to 1.48, marking a decrease of 0.01.
For Current Ratio (X), as of Mar 24, the value is 1.80. This value is within the healthy range. It has increased from 1.37 (Mar 23) to 1.80, marking an increase of 0.43.
For Quick Ratio (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 1.20, marking an increase of 0.37.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.11. This value is within the healthy range. It has increased from 3.84 (Mar 23) to 4.11, marking an increase of 0.27.
For Interest Coverage Ratio (X), as of Mar 24, the value is 33.55. This value is within the healthy range. It has increased from 19.95 (Mar 23) to 33.55, marking an increase of 13.60.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 22.84. This value is within the healthy range. It has increased from 13.47 (Mar 23) to 22.84, marking an increase of 9.37.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,398.91. It has increased from 1,621.01 (Mar 23) to 2,398.91, marking an increase of 777.90.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 1.61, marking an increase of 0.46.
For EV / EBITDA (X), as of Mar 24, the value is 12.75. This value is within the healthy range. It has increased from 12.44 (Mar 23) to 12.75, marking an increase of 0.31.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 1.14 (Mar 23) to 1.60, marking an increase of 0.46.
For Price / BV (X), as of Mar 24, the value is 4.03. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 23) to 4.03, marking an increase of 0.58.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 1.14 (Mar 23) to 1.60, marking an increase of 0.46.
For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Kingfa Science & Technology (India) Ltd as of June 26, 2025 is: 2,746.17

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 26, 2025, Kingfa Science & Technology (India) Ltd is Overvalued by 11.27% compared to the current share price 3,095.00

Intrinsic Value of Kingfa Science & Technology (India) Ltd as of June 26, 2025 is: 5,376.01

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 26, 2025, Kingfa Science & Technology (India) Ltd is Undervalued by 73.70% compared to the current share price 3,095.00

Last 5 Year EPS CAGR: 95.76%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (312.58 cr) compared to borrowings (42.83 cr), indicating strong financial stability. The company has shown consistent growth in sales (317.92 cr) and profit (54.33 cr) over the years.	The stock has a low average ROCE of 11.00%, which may not be favorable. The stock has a high average Working Capital Days of 73.42, which may not be favorable. The stock has a high average Cash Conversion Cycle of 62.17, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kingfa Science & Technology (India) Ltd:
1. Net Profit Margin: 8.23%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 28.66% (Industry Average ROCE: 16.41%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 20.81% (Industry Average ROE: 12.42%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 22.84
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.2
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 24.5 (Industry average Stock P/E: 40.58)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.05
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Kingfa Science & Technology (India) Ltd. is a Public Limited Listed company incorporated on 10/11/1983 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L25209TN1983PLC010438 and registration number is 010438. Currently Company is involved in the business activities of Manufacture of other plastics products. Company's Total Operating Revenue is Rs. 1744.69 Cr. and Equity Capital is Rs. 12.11 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Plastics - Plastic & Plastic Products	Dhun Building, 3rd Floor, Chennai (Madras) Tamil Nadu 600002	cs@kingfaindia.com http://www.kingfaindia.com

Management
Name	Position Held
Mr. Bo Jingen	Managing Director
Mr. Doraiswami Balaji	Executive Director
Mr. Wu Xiaohui	Non Exe.Non Ind.Director
Mr. Dilip Dinkar Kulkarni	Independent Director
Ms. Nilima Ramrao Shinde	Independent Director
Mr. Ramachandran Sudhinder	Independent Director

FAQ

What is the intrinsic value of Kingfa Science & Technology (India) Ltd?

Kingfa Science & Technology (India) Ltd's intrinsic value (as of 25 June 2025) is ₹2746.17 — 11.27% lower the current market price of 3,095.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,752 Cr. market cap, FY2025-2026 high/low of ₹3,954/1,996, reserves of 716 Cr, and liabilities of 1,156 Cr.

What is the Market Cap of Kingfa Science & Technology (India) Ltd?

The Market Cap of Kingfa Science & Technology (India) Ltd is 3,752 Cr..

What is the current Stock Price of Kingfa Science & Technology (India) Ltd as on 25 June 2025?

The current stock price of Kingfa Science & Technology (India) Ltd as on 25 June 2025 is 3,095.

What is the High / Low of Kingfa Science & Technology (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Kingfa Science & Technology (India) Ltd stocks is ₹3,954/1,996.

What is the Stock P/E of Kingfa Science & Technology (India) Ltd?

The Stock P/E of Kingfa Science & Technology (India) Ltd is 24.5.

What is the Book Value of Kingfa Science & Technology (India) Ltd?

The Book Value of Kingfa Science & Technology (India) Ltd is 602.

What is the Dividend Yield of Kingfa Science & Technology (India) Ltd?

The Dividend Yield of Kingfa Science & Technology (India) Ltd is 0.32 %.

What is the ROCE of Kingfa Science & Technology (India) Ltd?

The ROCE of Kingfa Science & Technology (India) Ltd is 30.6 %.

What is the ROE of Kingfa Science & Technology (India) Ltd?

The ROE of Kingfa Science & Technology (India) Ltd is 23.2 %.

What is the Face Value of Kingfa Science & Technology (India) Ltd?

The Face Value of Kingfa Science & Technology (India) Ltd is 10.0.